Diabetic pulmonary microangiopathy - fact or fiction?
Related Experiment Video
Updated: Jun 2, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Krzysztof Kuziemski1, Krzysztof Specjalski, Ewa Jassem
1Department of Allergology, Medical University, Gdansk, Poland. k.kuziemski@gumed.edu.pl
Abstract:
Elevated levels of serum glucose have deleterious effects on the walls of blood vessels, leading to microangiopathy. Such a destructive process involves also pulmonary circulation, where it is referred to as diabetic pulmonary microangiopathy. This hypothesis has been confirmed in histopathologic examinations of pulmonary parenchyma, as well as in pulmonary function tests. However, so far there have been no clinical implications of these findings. Another phenomenon requiring further discussion involves diabetics with clinically silent respiratory dysfunction. That may result from significant vascular and ventilation reserves that compensate for partial loss of pulmonary parenchyma in the course of diabetes. In this review, we present an overview of the available publications on pulmonary microangiopathy and its influence on the functioning of the respiratory system.
Insights
High blood sugar damages blood vessels, causing diabetic pulmonary microangiopathy. This review explores its impact on lung function, even when respiratory issues are silent.
Area of Science:
- Pulmonary Medicine
- Endocrinology
- Vascular Biology
Background:
- Elevated serum glucose levels are known to cause microangiopathy, affecting blood vessels throughout the body.
- Diabetic pulmonary microangiopathy specifically impacts the lung's vasculature, a process supported by histopathological and functional evidence.
- Despite evidence, clinical implications and silent respiratory dysfunction in diabetic patients remain underexplored.
Purpose of the Study:
- To review existing literature on diabetic pulmonary microangiopathy.
- To discuss the influence of this condition on respiratory system function.
- To highlight the phenomenon of clinically silent respiratory dysfunction in diabetes.
Main Methods:
- Literature review of publications on pulmonary microangiopathy in diabetes.
- Analysis of histopathologic findings in pulmonary parenchyma.
- Examination of pulmonary function test results.
Main Results:
- Histopathological and pulmonary function tests confirm diabetic pulmonary microangiopathy.
- Diabetic individuals may exhibit silent respiratory dysfunction due to compensatory vascular and ventilation reserves.
- The clinical significance of these findings requires further investigation.
Conclusions:
- Diabetic pulmonary microangiopathy is a recognized pathological process affecting lung vasculature.
- Compensatory mechanisms can mask respiratory dysfunction in diabetic patients, necessitating further clinical correlation.
- This review underscores the need for greater awareness and research into the pulmonary complications of diabetes.
Related Concept Videos
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Foot Ulcer
Diabetic Neuropathy
Peripheral Artery Disease I: Introduction
Complications of Diabetes Mellitus
